TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.120
+0.040 (3.70%)
At close: Jun 17, 2025, 4:00 PM
1.100
-0.020 (-1.79%)
After-hours: Jun 17, 2025, 7:53 PM EDT

TherapeuticsMD Market Cap

TherapeuticsMD has a market cap or net worth of $12.96 million as of June 18, 2025. Its market cap has decreased by -47.30% in one year.

Market Cap
12.96M
Enterprise Value
14.19M
1-Year Change
-47.30%
Ranking
Category
Stock Price
$1.12

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y10 Years10YFull HistoryMax27 Mar 201216 Jun 2025Max ▾20132014201520162017201820192020202120222023202420250500M1,000M1,500M13M

Since March 27, 2012, TherapeuticsMD's market cap has decreased from $210.70M to $12.96M, a decrease of -93.85%. That is a compound annual growth rate of -19.00%.

History

DateMarket Cap% Change
Jun 16, 202512.50M26.26%
Dec 31, 20249.90M-58.40%
Dec 29, 202323.80M-55.01%
Dec 30, 202252.90M-64.99%
Dec 31, 2021151.10M-54.23%
Dec 31, 2020330.10M-49.70%
Dec 31, 2019656.20M-27.60%
Dec 31, 2018906.30M-30.67%
Dec 29, 20171.31B15.24%
Dec 30, 20161.13B-38.50%
Dec 31, 20151.84B165.63%
Dec 31, 2014694.30M-8.08%
Dec 31, 2013755.30M144.20%
Dec 31, 2012309.30M46.80%
View and export this data all the way back to 2012. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 735.57B
Johnson & Johnson 377.99B
Novo Nordisk 355.28B
AbbVie 337.52B
UnitedHealth Group 284.42B
Abbott Laboratories 235.96B
Novartis AG 234.52B
AstraZeneca 231.58B
Market Cap Rankings